Log In

Forgot Password?
Create New Account

Loading... please wait

2021 Annual Meeting | General Neurology Posters

This program spans the entire conference
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
General Neurology
0.00 credit
COVID-19

Program Materials Program Evaluations

Event Timeline
07:00 AM - 05:00 PM EDT Abstract 001 - Modulation of cerebral arterial flow by anodic transcranial direct current electrical stimulation
Edgar Botello-Hernandez
07:00 AM - 05:00 PM EDT Abstract 002 - Utilization of Diagnostic Testing for COVID-19 Patients Suffering from Encephalopathy
Puja Jain, MD
07:00 AM - 05:00 PM EDT Abstract 003 - Cerebrospinal fluid interleukine-8 to distinguish Guillain-Barré Syndrome from chronic inflammatory demyelinating polyneuropathy
Gautier Breville, MD
07:00 AM - 05:00 PM EDT Abstract 004 - Electrophysiological And Magnetic Resonance Neurography Correlate Of Non Traumatic Common Peroneal Neuropathy
Divya M. Radhakrishnan, MD, DM Neurology
07:00 AM - 05:00 PM EDT Abstract 005 - Natural Language Processing Model to Extract Acute Abnormalities from CT Head Reports
Victor M. Torres-Lopez, MA
07:00 AM - 05:00 PM EDT Abstract 006 - Altered Brain in Carpal Tunnel Syndrome: A Meta-analysis of Structural and Functional Magnetic Resonance Imaging
Mohamed Fahmy Doheim
07:00 AM - 05:00 PM EDT Abstract 007 - HTT CAG Repeat Length Variation in Huntington Disease (HD) Patients: Experience from a US Reference Laboratory
Sat Dev Batish, PhD, FAAN
07:00 AM - 05:00 PM EDT Abstract 008 - Infarct and Penumbra Growth Rate usage in Machine Learning Model Improves Prognostic Outcome Prediction in Acute Ischemic Stroke
Srinivasa Rao Kundeti
07:00 AM - 05:00 PM EDT Abstract 009 - Permanent Intrathecal Access in Domestic Piglet for Biomarker and Discovery Studies
Megan G. Pino
07:00 AM - 05:00 PM EDT Abstract 010 - KonectomTM Smartphone-based Digital Outcome Assessments for Adults Living with Spinal Muscular Atrophy (SMA): A Conceptual Framework
Eduardo Arteaga Bracho
07:00 AM - 05:00 PM EDT Abstract 011 - Neurological Manifestations of SARS-CoV-2 Infection in Type 2 Diabetes
Parisorn Thepmankorn
07:00 AM - 05:00 PM EDT Abstract 012 - Coronavirus Disease 2019 in Patients With Prior Ischemic Stroke
Carolina Gil Tommee, MD
07:00 AM - 05:00 PM EDT Abstract 013 - Neurological Manifestations of Patients Hospitalized with COVID-19 Diagnosis at OLSU-S
Junaid Ansari, MD
07:00 AM - 05:00 PM EDT Abstract 014 - COVID-19 in patients with neurological disorders
Carolina Gil Tommee, MD
07:00 AM - 05:00 PM EDT Abstract 015 - Neurological biomarkers in COVID-19: Comparing patient biomarkers across hospital discharge status
Cian Dabrowski, MS
07:00 AM - 05:00 PM EDT Abstract 016 - Neurological Disorders associated with COVID-19 in Singapore
Rebecca H. Hoe, MBBS, MRCP
07:00 AM - 05:00 PM EDT Abstract 017 - Acute Encephalopathy in COVID-19 patients- Early Experience from an Inner-City Hospital
Wan Yee Kong, MBBS
07:00 AM - 05:00 PM EDT Abstract 018 - Long-Segment Peripheral Neuropathies after COVID-19: Magnetic Resonance Neurography Findings
07:00 AM - 05:00 PM EDT Abstract 019 - Effect of Neurological Manifestations on SARS-CoV-2 Infection Prognosis using Machine Learning Models
Parisorn Thepmankorn
07:00 AM - 05:00 PM EDT Abstract 020 - COVID-19 in Patients With Pre-existing Neurologic Disorders: Clinical Course and Outcomes
Svetlana Blitshteyn, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 021 - Effect Sizes of Vascular Risk Factors for Stroke Occurrence by Age Among West Africans
Mayowa Owolabi, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 022 - Idiopathic Intracranial Hypertension in a Pregnant Female Improved with Venous Sinus Stenting
Hera A. Kamdar, MD
07:00 AM - 05:00 PM EDT Abstract 023 - Neurologic Manifestations in Polycythemia; A 5 Year Study from South India
Vivek Bhat
07:00 AM - 05:00 PM EDT Abstract 024 - Large Bilateral Hemorrhagic Infarctions Secondary to Cerebral Venous Sinus Thrombosis in a Patient with Focal Segmental Glomerulosclerosis: A Case Report
Noelia C. Morales, MD
07:00 AM - 05:00 PM EDT Abstract 025 - Widespread Infarction: When a Spinal Cord Infarct Involves More than Just the Cord
Venus Barlas
07:00 AM - 05:00 PM EDT Abstract 026 - Prolonged reversible focal neurologic deficits in the elderly with contralateral EEG slowing: a post-ictal, migrainous, or vascular phenomenon?
Kelsey M. Smith, MD
07:00 AM - 05:00 PM EDT Abstract 027 - Hereditary hemorrhagic telangiectasia and pulmonary and cerebral complications: A case report and literature review
Ah Ryung Lim
07:00 AM - 05:00 PM EDT Abstract 028 - Calf claudication secondary to normal pressure hydrocephalus, a case report
David E. Kvarnberg, MD
07:00 AM - 05:00 PM EDT Abstract 029 - Eclampsia Resulting in Posterior Reversible Encephalopathy Syndrome with Spinal Cord and Optic Nerve Involvement
Negar Moheb, MD
07:00 AM - 05:00 PM EDT Abstract 030 - The Virtual Neurologic Exam: Instructional Videos and Guidance for the COVID-19 Era
Mariam Al Hussona, MB BCh BAO
07:00 AM - 05:00 PM EDT Abstract 031 - Patients and Providers Satisfaction with Telemedicine at the Beginning of the COVID 19 Pandemic- A Neurology Department Experience
Omar M. Said
07:00 AM - 05:00 PM EDT Abstract 032 - Teleneurology As a Tool to Increase Patient Visit Compliance During the COVID-19 Pandemic
Shayan Torabi Moghaddam, DO
07:00 AM - 05:00 PM EDT Abstract 033 - Implementation and Evaluation of a Teleneurology Clinic Serving Vulnerable Populations in Zambia During the COVID-19 Pandemic
Melody T. Asukile, MBBS
07:00 AM - 05:00 PM EDT Abstract 034 - Evaluation of Patient Financial Savings from Telemedicine Implementation in a Neurology Department in a Major Urban Academic Medical Center
Melissa Reider-Demer, DNP, MN, CNP
07:00 AM - 05:00 PM EDT Abstract 035 - Evaluation of Patient and Clinician Perspectives for New and Return Ambulatory Teleneurology Visits, with special attention to subspecialty differences
Jessica Falco-Walter, MD
07:00 AM - 05:00 PM EDT Abstract 036 - Adapting the Neurology Resident Clinic Workflow in a Large Urban Hospital During the COVID-19 Pandemic: Did it Work?
Nirav Sanghani, MBBS
07:00 AM - 05:00 PM EDT Abstract 037 - How to build a residency training track for future Neurohospitalists: an AAN survey
Jonathan Donnelly, MB BCh BaO
07:00 AM - 05:00 PM EDT Abstract 038 - How Do Patients and Physicians Experience the Same Teleneurology Encounter?
Sujata P. Thawani, MD
07:00 AM - 05:00 PM EDT Abstract 039 - Resident-Based Patient Triage Improves Acuity of Outpatients in a Neurology Urgent Care Clinic Setting
Micah Etter, MD
07:00 AM - 05:00 PM EDT Abstract 040 - Outcomes of a QI/QA Project to Improve Hand-offs in an Urban Neurology Residency Program
Osama M. Abu-hadid, MD
07:00 AM - 05:00 PM EDT Abstract 041 - Newsworthiness of Neurological Research
Isha Snehal, MBBS
07:00 AM - 05:00 PM EDT Abstract 042 - Abstract: Fast Neuro - Expedited Access to Neurology Clinic
Shuvro Roy, MD
07:00 AM - 05:00 PM EDT Abstract 043 - A Value Assessment of Diagnostic Modalities for Trigeminal Sensory Neuropathy
Sherri A. Braksick, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 044 - Clinical and Epidemiological Characteristics of Patients with TTR Mutations and Polyneuropathy Manifestations of Hereditary Transthyretin Amyloidosis: Insights from a Genetic Testing Program
Sami L. Khella, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 045 - A Patient-Focused Survey to Assess the Effects of the COVID-19 Pandemic and Social Policies on People with Muscular Dystrophy
Leann Lewis
07:00 AM - 05:00 PM EDT Abstract 046 - Stroke and dementia, leading causes of neurological disability and death, potential for prevention
Abolfazl Avan, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 047 - Dog Ownership or Therapy to Potentially Ameliorate Burden of Neurological Disease
Catherine Boldig, DO
07:00 AM - 05:00 PM EDT Abstract 048 - COVID19 Neurological Manifestations in the Veteran’s Community
Leila Saadatpour, MD
07:00 AM - 05:00 PM EDT Abstract 049 - Analysis of ALS Biospecimen Demand and Utilization of Samples for the National ALS Biorepository
07:00 AM - 05:00 PM EDT Abstract 050 - Following the trail in multiple cranial neuropathy: a case series in a hospital in Bogotá, Colombia
Habib Georges Moutran Barroso, MD
07:00 AM - 05:00 PM EDT Abstract 051 - Disease Burden and Healthcare Utilization Among Patients with Acute Intermittent Porphyria Experiencing Chronic Neuropathy: Analyses from a National Healthcare Database
Angelika Erwin
07:00 AM - 05:00 PM EDT Abstract 052 - Can’t Move My Face Or Feel My Body: A COVID-19 Associated Guillain Barre variant.
Batool A. Hussain, MD, MBBS
07:00 AM - 05:00 PM EDT Abstract 053 - Myasthenia Gravis in a patient being treated with pembrolizumab in the absence of anti-acetylcholine receptor antibodies
Gaurav Kiri
07:00 AM - 05:00 PM EDT Abstract 054 - Utilizing Holistic strategies for improvement of quality of life of patients with Generalized Myasthenia Gravis.
Nakul Katyal, MD
07:00 AM - 05:00 PM EDT Abstract 055 - Brachial Plexopathy: A Rare Association With A Wasp Sting
Saad Karim, MD
07:00 AM - 05:00 PM EDT Abstract 056 - SARS-CoV-2 Associated Guillain-Barré Syndrome with Dysautonomia
Sydney V. Palka, MD
07:00 AM - 05:00 PM EDT Abstract 057 - Immunoglobulin-Responsive Posterior Interosseous Neuropathy: A Variant of Multifocal Motor Neuropathy?
Michael Isfort, MD
07:00 AM - 05:00 PM EDT Abstract 058 - Acute-Onset Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in a well-controlled diabetic patient without complications
Gaurav Kiri
07:00 AM - 05:00 PM EDT Abstract 059 - Guillain-Barre Syndrome preceded by SARS-CoV-2 Infection in Setting of L2-L4 Radiculopathy/Plexopathy
Gaurav Kathuria, MD
07:00 AM - 05:00 PM EDT Abstract 060 - Refractory Localization Related Epilepsy Secondary to Intracranial Arachnoid Cyst: A Case Report and an algorithmic approach for evaluation and management
Shruthishree Sukumar
07:00 AM - 05:00 PM EDT Abstract 061 - SARS-CoV-2 Presenting as Posterior Reversible Encephalopathy Syndrome (PRES) in Absence of Respiratory Symptoms.
Paul Wilkerson, DO
07:00 AM - 05:00 PM EDT Abstract 062 - A Pattern Analysis of Cerebral Metastasis Using FDG PET Imaging
Guhan Ramamurthy, MD, DM
07:00 AM - 05:00 PM EDT Abstract 063 - Sever hyperammonemic encephalopathy post sleeve gastrectomy
Lubna E. El Sheikh, Jr., MBBS
07:00 AM - 05:00 PM EDT Abstract 064 - A case of Delayed and Reversible Chemotherapy-Induced Leukoencephalopathy
Junaid H. Siddiqui, MD
07:00 AM - 05:00 PM EDT Abstract 065 - Wernicke Encephalopathy Secondary to Acute Gastrointestinal Pathology
Igor Zilberman, MD
07:00 AM - 05:00 PM EDT Abstract 066 - Acute Wernicke’s Encephalopathy after Hemorrhagic Shock in a Non-alcoholic Patient
Maryum Shoukat, MD
07:00 AM - 05:00 PM EDT Abstract 067 - The Red Herring that Mimicked a Chameleon
Faizan Aslam, MBBS
07:00 AM - 05:00 PM EDT Abstract 068 - A Pictorial Essay of Corpus Callosum
Lakshmi N. Ranganathan, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 069 - Abnormal Enlargement of Virchow-Robin spaces resulting in Paresthesia and Weakness
Jaspreet Johal, MD
07:00 AM - 05:00 PM EDT Abstract 070 - Diagnosis and Management of a Sibling Pair With Hereditary Transthyretin Amyloidosis Associated With F44S (p.Phe64Ser) Transthyretin Variant: A Case Report
Eugenie Girouard, MD
07:00 AM - 05:00 PM EDT Abstract 071 - A Curious Case of Gabapentin-Induced Increased Urinary Frequency
Mustafa Mohammed, MD, MBBS
07:00 AM - 05:00 PM EDT Abstract 072 - SNORD118 negative Labrune syndrome
Matheus Alves A. Silva, MD
07:00 AM - 05:00 PM EDT Abstract 073 - Classification of ataxic gait by shallow classifiers
07:00 AM - 05:00 PM EDT Abstract 074 - Gabapentin-Induced Myokymia: A Case Report
Aimalohi Esechie, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 075 - Evaluation of New-Onset Seizures in a Safety-Net Hospital Emergency Department
Fatima Zuberi, MD, BA
07:00 AM - 05:00 PM EDT Abstract 076 - Bariatric Berberi; The Other Thiamine Deficiency
Michael B. Beeler, DO
07:00 AM - 05:00 PM EDT Abstract 077 - Irreversible Cerebellar Ataxia Following Treatment with 5-Fluorouracil
Deborah Rose, MD
07:00 AM - 05:00 PM EDT Abstract 078 - No Laughing Matter: A Case of Nitrous Oxide Toxicity and Factitious Disorder
Han S. Lee
07:00 AM - 05:00 PM EDT Abstract 079 - Transplanted patients and cerebrospinal fluid
Carla F. Bolano Diaz, MD
07:00 AM - 05:00 PM EDT Abstract 080 - A systematic review of behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate in real-world studies
Bernhard Steinhoff
07:00 AM - 05:00 PM EDT Abstract 081 - Chronic Methanol Toxicity Through Topical and Inhalational Routes Presenting as Vision Loss and Restricted Diffusion of the Optic Nerves on MRI: A Case Report and Literature Review
Christianne Mojica
07:00 AM - 05:00 PM EDT Abstract 082 - Intravenous Glucose without Thiamine is Associated with Increased Mortality in Hospitalized Patients with Acute Encephalopathy
Daniel Zhou, MD
07:00 AM - 05:00 PM EDT Abstract 083 - Vitamin B6 (pyridoxine) Toxicity and OTC Supplements
Madhureeta Achari, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 084 - Supplemental Thiamine is not Associated with Mental Status Improvement in Patients Hospitalized with Acute Encephalopathy
Daniel Zhou, MD
07:00 AM - 05:00 PM EDT Abstract 085 - Neurological Risks and Benefits of Medical Cannabis Ase: A Cross-sectional Analysis of Health Care Professionals’ Knowledge
Jessica Rice, MD
07:00 AM - 05:00 PM EDT Abstract 086 - Serotonin Receptor Activity Profiles for Nine Commercialized Ergot Alkaloids Correspond to Known Risks of Fibrosis and Hallucinations
Robert Fishman, MD
07:00 AM - 05:00 PM EDT Abstract 087 - Examining Associations Between Cannabinoid Products and Fall Risk in Patients with Neurological Conditions: Multiple Sclerosis, Polyneuropathy, Parkinson’s Disease, and Stroke
Janardan S. Sivapalan
07:00 AM - 05:00 PM EDT Abstract 088 - A Cell-Penetrating Peptide (CPP) Did Not Decrease 150-kDa BoNT/A Toxin Adsorption to Surfaces or Increase Toxin Potency or Duration in a Prototype Formulation
07:00 AM - 05:00 PM EDT Abstract 089 - Unusual, Stable Phenotype in Patient with Ser70Arg TTR Mutation on Diflunisal Therapy
Sean Mooney, MB BCh BAO
07:00 AM - 05:00 PM EDT Abstract 090 - Time to Event Milestones in Patients With Amyotrophic Lateral Sclerosis Treated With IV Edaravone: Results From a US Administrative Claims Analysis
Melissa Hagan
07:00 AM - 05:00 PM EDT Abstract 091 - The Use of Medical Cannabis in the Treatment Comorbid Anxiety and Depression
Laszlo Mechtler, MD, FASN, FAAN
07:00 AM - 05:00 PM EDT Abstract 093 - Neurofilament Light Chain (NfL) as a Potential Biomarker of Treatment Response in Hereditary Transthyretin-Mediated Amyloidosis: Data from the Patisiran Global OLE Study
Michael J. Polydefkis, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 094 - Increase in Polyneuropathy Disability Stage Does Not Predict Neuropathic Progression in Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy Receiving Inotersen: Results from the NEURO-TTR Study
Aaron Yarlas, PhD
07:00 AM - 05:00 PM EDT Abstract 095 - A Phase 1, Multicenter, Open Label, Single-Ascending Dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of AP-101 in Familial and Sporadic Amyotrophic Lateral Sclerosis (ALS)
Angela L. Genge, MD
07:00 AM - 05:00 PM EDT Abstract 096 - Phase 1/2a, Double-blind, Placebo-controlled Study of Ropinirole Hydrochloride Remedy for ALS (ROPALS trial) Based On The iPSC Drug Repositioning
Shinichi Takahashi, MD
07:00 AM - 05:00 PM EDT Abstract 097 - Immune Checkpoint Inhibitor use in Patients with Pre-existing Neurological Autoimmune Diseases: A Case Series
Andrew R. Snavely
07:00 AM - 05:00 PM EDT Abstract 098 - Medical Cannabis in the Treatment of Neuropathy
Paul B. Hart
Faculty Disclosures
No disclosure on file
Achal K. Srivastava, MD, FAAN Dr. Srivastava has nothing to disclose.
Iram Zaman, DO, FAAN Dr. Zaman has nothing to disclose.
Mariam H. Haider, BS Mariam Haider has nothing to disclose.
Rebecca H. Hoe, MBBS, MRCP Dr. Hoe has nothing to disclose.
John L. Berk John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam Pharmaceuticals. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca/IONIS. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eidos/BridgBio. John L. Berk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia Therapeutics. John L. Berk has received research support from Alnylam . John L. Berk has received research support from Ionis. John L. Berk has received research support from Eidos/Bridgbio.
Rodrigo Zepeda Garcia, MD The institution of Dr. Zepeda Garcia has received research support from NIH.
Angela Paradis Angela Paradis has received personal compensation for serving as an employee of Biogen. An immediate family member of Angela Paradis has received personal compensation for serving as an employee of Biogen. Angela Paradis has received stock or an ownership interest from Biogen. An immediate family member of Angela Paradis has received stock or an ownership interest from Biogen.
Danielle Sandsmark, MD The institution of Dr. Sandsmark has received research support from NINDS.
Zainab Mohammed Miss Mohammed has nothing to disclose.
Madhu S. Jasti, MD Dr. Jasti has nothing to disclose.
Pria Anand, MD Dr. Anand has nothing to disclose.
Lauren H. Sansing, MD Dr. Sansing has nothing to disclose.
Jessica Rice, MD Dr. Rice has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich Pharmaceuticals.
Richa Sharma, MD Dr. Sharma has received research support from NIH. Dr. Sharma has received intellectual property interests from a discovery or technology relating to health care.
Brett L. Cucchiara, MD Dr. Cucchiara has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Elseiver. Dr. Cucchiara has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Bayer. Dr. Cucchiara has received publishing royalties from a publication relating to health care.
Terese Gullo, MD Miss Gullo has nothing to disclose.
Victor M. Torres-Lopez, MA Mr. Torres-Lopez has nothing to disclose.
Vicente Villanueva No disclosure on file
Megan T. Donnelly, DO No disclosure on file
Fatima Zuberi, MD, BA Fatima Zuberi has nothing to disclose.
Kayoko Saito No disclosure on file
Hera A. Kamdar, MD Dr. Kamdar has nothing to disclose.
Alrabi Tawil, MD, FAAN Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DYNE Therapeutics. Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead Pharma. Dr. Tawil has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum Therapeutics. Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acceleron Pharma. Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT Pharma. Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharma. Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for miRecule. The institution of Dr. Tawil has received research support from Friends of FSH Research. The institution of Dr. Tawil has received research support from FSH Society. The institution of Dr. Tawil has received research support from NIH. The institution of Dr. Tawil has received research support from Fulcrum. Dr. Tawil has received intellectual property interests from a discovery or technology relating to health care. Dr. Tawil has received publishing royalties from a publication relating to health care.
Viktor Perovic, MD Dr. Perovic has nothing to disclose.
Boulenouar Mesraoua, MD, FAAN Dr. Mesraoua has nothing to disclose.
Ayaz M. Khawaja, MD Dr. Khawaja has nothing to disclose.
Daniel S. Newman, MD Dr. Newman has nothing to disclose.
Lance E. Steward, PhD Dr. Steward has received personal compensation for serving as an employee of Allergan Aesthetics an AbbVie Company. Dr. Steward has received stock or an ownership interest from Allergan Aesthetics an AbbVie Company.
Henrik Klitgaard Mr. Klitgaard has received personal compensation for serving as an employee of UCB Inc. Mr. Klitgaard has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for UCB Inc.
Sabrina Sacconi, MD Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LUPIN. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMICUS. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALEXION. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for FULCRUM THERAPEUTICS. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for AXELYS. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for OLOGY. The institution of Dr. Sacconi has received research support from Solve FSHD.
George C. Diaz, MD Dr. Diaz has nothing to disclose.
Mihir Kakara, MD Dr. Kakara has nothing to disclose.
Laszlo Mechtler, MD, FASN, FAAN Dr. Mechtler has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Jushi Inc. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Mechtler has received stock or an ownership interest from Jushi Co.. The institution of Dr. Mechtler has received research support from The Harry Dent Family Foundation, Inc. The institution of Dr. Mechtler has received research support from Amgen/Novartis. The institution of Dr. Mechtler has received research support from Alder/ Lundbeck. The institution of Dr. Mechtler has received research support from Abbvie/Allergan. The institution of Dr. Mechtler has received research support from Miles for Migraine. The institution of Dr. Mechtler has received research support from American Migraine Foundation. The institution of Dr. Mechtler has received research support from Charlotte's Web.
Brian J. Villafuerte Trisolini, MD Dr. Villafuerte Trisolini has nothing to disclose.
Vineet Punia, MD Dr. Punia has nothing to disclose.
Gaurav Kathuria, MD Dr. Kathuria has nothing to disclose.
Kan Ding, MD The institution of Dr. Ding has received research support from National Institute of Aging. The institution of Dr. Ding has received research support from NINDS.
Jasmine Koh, MBBS Dr. Koh has nothing to disclose.
Kelly Rich, MS, CGC Ms. Rich has nothing to disclose.
Wendy E. Kaye, PhD Dr. Kaye has received personal compensation for serving as an employee of McKing Consulting Corporation. Dr. Kaye has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Association for the Protection of Human Research Participants.
Thanh-Tu Nguyen, MD Dr. Nguyen has nothing to disclose.
Micah Etter, MD Dr. Etter has nothing to disclose.
Edgar Botello-Hernandez Edgar Botello-Hernandez has nothing to disclose.
Anurag Sahoo, MD Dr. Sahoo has nothing to disclose.
John Ko, PharmD, MS Dr. Ko has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Dr. Ko has received personal compensation for serving as an employee of Novartis. Dr. Ko has received stock or an ownership interest from Alnylam Pharmaceuticals. Dr. Ko has received stock or an ownership interest from Novartis.
Kevin Tan, MD, FAAN Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck.
Carlos Lara, MD Dr. Lara has nothing to disclose.
Mary Reilly, MD, FRCP, FRCPI The institution of Mary Reilly, MD, FRCP, FRCPI has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alynlam. Mary Reilly, MD, FRCP, FRCPI has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AKCEA. Mary Reilly, MD, FRCP, FRCPI has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inflectis. The institution of Mary Reilly, MD, FRCP, FRCPI has received research support from MRC. The institution of Mary Reilly, MD, FRCP, FRCPI has received research support from NIH. The institution of Mary Reilly, MD, FRCP, FRCPI has received research support from MDA.
Naluca Mwendaweli, MBChB NALUCA MWENDAWELI has nothing to disclose.
Divya M. Radhakrishnan, MD, DM Neurology Dr. Radhakrishnan has received research support from Indian Council of Medical Research, New Delhi, India. Dr. Radhakrishnan has received research support from World Federation of Neurology .
Tian Ming Tu, MD Dr. Tu has nothing to disclose.
Yihui Goh, MBBS Dr. Goh has nothing to disclose.
Maitreyi Murthy, MD Dr. Murthy has nothing to disclose.
Monica E. Maher, MD Dr. Maher has nothing to disclose.
Farng-Yang Foo, MD Dr. Foo has nothing to disclose.
Juan F. Gongora Rivera, MD, MSc Dr. Gongora Rivera has nothing to disclose.
John M. Stern, MD, FAAN Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharma. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for LivaNova. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Stern has stock in DEARhealth. Dr. Stern has stock in Ceribell. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
Deepti Chrusciel, MD Dr. Chrusciel has nothing to disclose.
Mark Agostini, MD Dr. Agostini has nothing to disclose.
Igor Zilberman, MD Dr. Zilberman has nothing to disclose.
Carl A. Gold, MD Dr. Gold has received personal compensation for serving as an employee of Stanford University. An immediate family member of Dr. Gold has received personal compensation for serving as an employee of Stanford University.
Justin A. Morrison Mr. Morrison has nothing to disclose.
Lukman F. Owolabi, PhD, MSc, FWAPC, FMCP Dr. Owolabi has nothing to disclose.
Alexandria Soto Ms. Soto has nothing to disclose.
Myrna Cardiel, MD Dr. Cardiel has nothing to disclose.
Eu Jene Choi No disclosure on file
Malgorzata Ciepielewska Malgorzata Ciepielewska has received personal compensation for serving as an employee of Mitsubishi Tanable Pharma America, Inc..
Gaurav Kiri Gaurav Kiri has nothing to disclose.
Charles Kassardjian, MD Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
Jeffrey Statland, MD Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ML Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epic Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Armatus . Dr. Statland has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity . Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum Therapeutics. Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Statland has received research support from NIH. The institution of Dr. Statland has received research support from FSHD Society. The institution of Dr. Statland has received research support from Friends of FSH Research. The institution of Dr. Statland has received research support from FSHD Canada. The institution of Dr. Statland has received research support from MDA.
Richard S. Finkel, MD, FAAN Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AveXis. Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catabasis. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Capricor. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ReveraGen. Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Finkel has received research support from AveXis. The institution of Dr. Finkel has received research support from Biogen. The institution of Dr. Finkel has received research support from Capricor. The institution of Dr. Finkel has received research support from Catabasis. The institution of Dr. Finkel has received research support from ReveraGen. The institution of Dr. Finkel has received research support from Roche. The institution of Dr. Finkel has received research support from Scholar Rock. Dr. Finkel has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Finkel has received intellectual property interests from a discovery or technology relating to health care. Dr. Finkel has received personal compensation in the range of $0-$499 for serving as a Speaker in workshop with National Academy of Sciences. Dr. Finkel has a non-compensated relationship as a advisor with n-Lorem Foundation that is relevant to AAN interests or activities. Dr. Finkel has a non-compensated relationship as a Board Member with EveryLife Foundation that is relevant to AAN interests or activities.
Katy Eichinger, PhD, PT, DPT, NCS Dr. Eichinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Fulcrum. Dr. Eichinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Avidity. Dr. Eichinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for DyneTherapeutic. Dr. Eichinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Eichinger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for FSHD Society. The institution of Dr. Eichinger has received research support from Charcot Marie Tooth Association.
Michaela Walker, MPH, CCRP Miss Walker has nothing to disclose.
Barbara M. Carvalho Miss Carvalho has nothing to disclose.
Elena Shanina, MD, FAAN Dr. Shanina has nothing to disclose.
Andrew C. Hui, MBBS, FRCP Dr. Hui has nothing to disclose.
Jaydeep M. Bhatt, MD Dr. Bhatt has nothing to disclose.
Nirav Sanghani, MBBS Dr. Sanghani has nothing to disclose.
Navya Joseph, MD Dr. Joseph has nothing to disclose.
Shinichi Takahashi, MD The institution of Dr. Takahashi has received research support from JSPS KAKENHI. The institution of Dr. Takahashi has received research support from Eisai Japan. The institution of Dr. Takahashi has received research support from Bayer Japan. The institution of Dr. Takahashi has received research support from Boehringer Ingelheim Japan.
Leann Lewis Leann Lewis has nothing to disclose.
Michael J. Polydefkis, MD, FAAN Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam Pharmaceuticals. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceutical . Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen-Idec. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer.
Alfredo Thomson, MD Dr. Thomson has nothing to disclose.
Guhan Ramamurthy, MD, DM Dr. Ramamurthy has nothing to disclose.
Kumar Rajamani, MD, FAAN Dr. Rajamani has nothing to disclose.
Roger E. Kelley, Jr., MD, FAAN Dr. Kelley has nothing to disclose.
Karima Benameur, MD Dr. Benameur has nothing to disclose.
Albert K. Akpalu, MD Dr. Akpalu has nothing to disclose.
Sean Mooney, MB BCh BAO Dr. Mooney has nothing to disclose.
Jaspreet Johal, MD Dr. Johal has nothing to disclose.
Sen Sheng, MD Dr. Sheng has nothing to disclose.
Susan Shin, MD Dr. Shin has nothing to disclose.
Lorraine Chishimba, MBChB, MMED Dr. Chishimba has nothing to disclose.
Patrick R. Burke, MD Dr. Burke has nothing to disclose.
Anu Venkat, MD Dr. Venkat has nothing to disclose.
Steve Garafalo Steve Garafalo has received personal compensation for serving as an employee of Biogen. Steve Garafalo has received stock or an ownership interest from Biogen.
Joseph I. Sirven, MD, FAAN Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona. Dr. Sirven has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Sirven has received publishing royalties from a publication relating to health care. Dr. Sirven has received personal compensation in the range of $10,000-$49,999 for serving as a Host/ Co producer with WJCT Public Media. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Federal Aviation Administration .
Ramon R. Diaz-Arrastia, MD, PhD, FAAN Dr. Diaz-Arrastia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ischemix, Inc. Dr. Diaz-Arrastia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pinteon Therapeutics. Dr. Diaz-Arrastia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BrainBox, LLC. Dr. Diaz-Arrastia has received stock or an ownership interest from BrainBox, LLC. Dr. Diaz-Arrastia has received stock or an ownership interest from NovaSignal . Dr. Diaz-Arrastia has received stock or an ownership interest from Nia Therpeutics. The institution of Dr. Diaz-Arrastia has received research support from National Institutes of Health. The institution of Dr. Diaz-Arrastia has received research support from Department of Defense.
Aftab Ahmad, MD Dr. Ahmad has nothing to disclose.
Ramiro G. Castro Apolo, MD Dr. Castro Apolo has nothing to disclose.
Shanna Patterson, MD Dr. Patterson has nothing to disclose.
Laura J. Balcer, MD, MSCE, FAAN An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia. Dr. Balcer has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for North American Neuro-Ophthalmology Society.
Paul B. Hart Mr. Hart has nothing to disclose.
Ajay Garg No disclosure on file
Bhanu Gogia, MBBS Dr. Gogia has nothing to disclose.
Alejandro Tobon, MD, FAAN Dr. Tobon has nothing to disclose.
Carrie Landess, MD Dr. Landess has received personal compensation for serving as an employee of Carrie Landess MD PA.
Hannah H. Zamore Hannah Zamore has nothing to disclose.
Michelle Cameron, MD Dr. Cameron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwich Biosciences/Jazz . Dr. Cameron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Adamas Pharmaceuticals. Dr. Cameron has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Cameron has received research support from National MS Society. The institution of Dr. Cameron has received research support from Department of Veterans Affairs. Dr. Cameron has received publishing royalties from a publication relating to health care.
Puja Jain, MD Dr. Jain has nothing to disclose.
Neil A. Busis, MD, FAAN Dr. Busis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Academy of Neurology. Dr. Busis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Today.
Mariam Al Hussona, MB BCh BAO Dr. Al Hussona has nothing to disclose.
Ron S. Broide, PhD Dr. Broide has received personal compensation for serving as an employee of Allergan Aesthetics / AbbVie.
Bernhard Steinhoff Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arvelle. Bernhard Steinhoff has received personal compensation in the range of $0-$499 for serving as a Consultant for B.Braun Melsungen. Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuraxpharm. Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Precisis. Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arvelle. Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Bernhard Steinhoff has received research support from UCB. The institution of Bernhard Steinhoff has received research support from Eisai. The institution of Bernhard Steinhoff has received research support from SK LIfe Science.
Cassie N. Chan, MD Dr. Chan has nothing to disclose.
Barry L. Menna, DO, FAAN Dr. Menna has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Multiple companies. Dr. Menna has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Multiple companies.
Leila Saadatpour, MD Dr. Saadatpour has nothing to disclose.
William D. Arnold, MD Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for La Hoffmann Roche. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadent Therapeutics . Dr. Arnold has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Arnold has received research support from NIH. The institution of Dr. Arnold has received research support from NMD Pharma. The institution of Dr. Arnold has received research support from Gilead Sciences. The institution of Dr. Arnold has received research support from CureSMA. Dr. Arnold has received intellectual property interests from a discovery or technology relating to health care.
Lakshmi N. Ranganathan, MD, FAAN Dr. Ranganathan has nothing to disclose.
Sachin Kedar, MD, FAAN Dr. Kedar has received intellectual property interests from a discovery or technology relating to health care.
Ismail M. Fahad, MBBS Dr. Fahad has nothing to disclose.
Wei Ping Kay Ng, MD Dr. Ng has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer.
Gabriella Garcia, MD Dr. Garcia has nothing to disclose.
Vivek Bhat Mr. Bhat has nothing to disclose.
Christen L. Shoesmith, MD, BSc, FAAN An immediate family member of Dr. Shoesmith has received personal compensation for serving as an employee of Lundbeck . The institution of Dr. Shoesmith has received research support from AL-Pharma. The institution of Dr. Shoesmith has received research support from Mitsubishi Tanabe. The institution of Dr. Shoesmith has received research support from Cytokinetics. The institution of Dr. Shoesmith has received research support from Sanofi. Dr. Shoesmith has received personal compensation in the range of $0-$499 for serving as a Drug application review with CADTH (Government of Canada). Dr. Shoesmith has a non-compensated relationship as a Canadian ALS Research Consortium Chair with ALS Canada that is relevant to AAN interests or activities.
Felix Rosenow No disclosure on file
Gautier Breville, MD Mr. Breville has nothing to disclose.
Martin Valis, MD Dr. Valis has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Valis has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Valis has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva.
Emre Aldinc Emre Aldinc has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Emre Aldinc has stock in Alnylam Pharmaceuticals.
Guido J. Falcone, MD The institution of Dr. Falcone has received research support from NIH. The institution of Dr. Falcone has received research support from AHA.
Bruce I. Ovbiagele, MD, MSc, FAAN Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to AAN interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to AAN interests or activities.
Mahsa Sadeghi, MD Dr. Sadeghi has nothing to disclose.
Prakash Kumar, MD No disclosure on file
Carla F. Bolano Diaz, MD Dr. Bolano Diaz has nothing to disclose.
Michel Toledano, MD Dr. Toledano has nothing to disclose.
Omar M. Said Omar Said has nothing to disclose.
Akshay Vaishnaw Akshay Vaishnaw, 22867 has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Akshay Vaishnaw, 22867 has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Editas Medicine. Akshay Vaishnaw, 22867 has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Scholar Rock. Akshay Vaishnaw, 22867 has received stock or an ownership interest from Alnylam Pharmaceuticals.
Kaeli Samson No disclosure on file
Fred Sarfo Fred Sarfo has nothing to disclose.
Madhureeta Achari, MD, FAAN Dr. Achari has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for McKinney-Taylor.
Vibhor Krishna No disclosure on file
Elina Zakin, MD The institution of Dr. Zakin has received research support from American Board of Psychiatry and Neurology.
Sami L. Khella, MD, FAAN Dr. Khella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ionis. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eidos.
Kishan Raj, MD Dr. Raj has nothing to disclose.
Raghav Govindarajan, MD, FAAN Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT pharma. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT pharma . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. The institution of Dr. Govindarajan has received research support from Band of Hope . The institution of Dr. Govindarajan has received research support from Alexion. Dr. Govindarajan has received publishing royalties from a publication relating to health care.
Brien J. Smith, MD, FAAN Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma.
Anastasia McManus Anastasia McManus has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Anastasia McManus has received stock or an ownership interest from Alnylam Pharmaceuticals.
Venus Barlas Venus Barlas has nothing to disclose.
Sama Astani, MD Dr. Astani has nothing to disclose.
M M Arun Shivaraman, NP, D M Dr. Shivaraman has nothing to disclose.
Robert Fishman, MD Dr. Fishman has nothing to disclose.
Vivian E. Drory, MD Prof. Drory has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Prof. Drory has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Prof. Drory has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medison Pharma. The institution of Prof. Drory has received research support from Neurosense Therapeutics. The institution of Prof. Drory has received research support from AB Science. The institution of Prof. Drory has received research support from Biogen. The institution of Prof. Drory has received research support from Neuralight.
Jin Nakahara, MD, PhD Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi-Tanabe. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Chugai. Prof. Nakahara has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Mitsubishi-Tanabe. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Daiichi-Sankyo. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Japanese Society for Internal Medicine. The institution of Prof. Nakahara has received research support from EA Pharma. The institution of Prof. Nakahara has received research support from JB. The institution of Prof. Nakahara has received research support from Eisai. The institution of Prof. Nakahara has received research support from Shionogi. The institution of Prof. Nakahara has received research support from Boehringer Ingelheim. The institution of Prof. Nakahara has received research support from Kyowa Kirin. The institution of Prof. Nakahara has received research support from Sumitomo Pharma. The institution of Prof. Nakahara has received research support from Otsuka. The institution of Prof. Nakahara has received research support from Chugai. The institution of Prof. Nakahara has received research support from Teijin. The institution of Prof. Nakahara has received research support from Mitsubishi-Tanabe.
Ah Ryung Lim Miss Lim has nothing to disclose.
Raymond M. Rivera Vergara, MD Dr. Rivera Vergara has nothing to disclose.
Carolina Gil Tommee, MD Dr. Gil Tommee has nothing to disclose.
Eric R. Wong, DO Dr. Wong has nothing to disclose.
Steven M. McKnight, MD Steven M. McKnight has nothing to disclose.
Naren Raj Arulprakash, MD Dr. Arulprakash has nothing to disclose.
Jawahar Marimuthu, DM Dr. Marimuthu has nothing to disclose.
Sat Dev Batish, PhD, FAAN Dr. Batish has received stock or an ownership interest from Quest Diagnostics.
Mitchell F. Brin, MD, FAAN Dr. Brin has received personal compensation for serving as an employee of Allergan. Dr. Brin has stock in Allergan.
Oldrich Vysata No disclosure on file
Christoph Kleinschnitz, MD Dr. Kleinschnitz has nothing to disclose.
Danny Samkutty, MD Dr. Samkutty has nothing to disclose.
Nina H. Kim, MD Dr. Kim has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam.
David M. Simpson, MD, FAAN Dr. Simpson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Simpson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz.
Timothy Lim No disclosure on file
Michelle A. Farrar Michelle A. Farrar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Michelle A. Farrar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Michelle A. Farrar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Michelle A. Farrar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Michelle A. Farrar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Sasha Alick-Lindstrom, MD, FACNS, FAES, FAAN Dr. Alick-Lindstrom has nothing to disclose.
Stanley Zimba, MBBS Dr. Zimba has nothing to disclose.
Frighton B. Mutete, MBChB Dr. Mutete has nothing to disclose.
Nicholas E. Johnson, MD, FAAN Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta Therapuetics. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne Therapeutics. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharma. Dr. Johnson has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for ML BIo . Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Johnson has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Arthex. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Juvena. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Entrada. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rgenta. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Angle Therapeutics. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AskBio. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum. Dr. Johnson has stock in Angle Therapeutics. Dr. Johnson has stock in Juvena Therapeutics. The institution of Dr. Johnson has received research support from Novartis. The institution of Dr. Johnson has received research support from Takeda . The institution of Dr. Johnson has received research support from AMO Pharma. The institution of Dr. Johnson has received research support from Sarepta. The institution of Dr. Johnson has received research support from Dyne Therapeutics. The institution of Dr. Johnson has received research support from AskBio. The institution of Dr. Johnson has received research support from Pepgen. The institution of Dr. Johnson has received research support from ML Bio. The institution of Dr. Johnson has received research support from Vertex. The institution of Dr. Johnson has received research support from Arthex. Dr. Johnson has received intellectual property interests from a discovery or technology relating to health care.
Alex Baeta Alex Baeta has nothing to disclose.
Navdeep Sangha, MD Dr. Sangha has nothing to disclose.
Keyvan Heshmati, MD Dr. Heshmati has nothing to disclose.
Wan Yee Kong, MBBS Dr. Kong has nothing to disclose.
Jennifer A. Kim, MD Dr. Kim has nothing to disclose.
Rohit Das, MD, FAAN Dr. Das has received personal compensation for serving as an employee of Concentra.
Mustafa Mohammed, MD, MBBS Dr. Mohammed has nothing to disclose.
Cian Dabrowski, MS Cian Dabrowski has nothing to disclose.
Shuvro Roy, MD Dr. Roy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Houman Khosravani, MD, PhD Dr. Khosravani has nothing to disclose.
Mohamed Fahmy Doheim Mr. Doheim has nothing to disclose.
Antoinette M. Harrison, PharmD Dr. Harrison has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma Amercia.
Deborah L. Carver, MD Dr. Carver has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan.
Andrea Hildebrand The institution of Ms. Hildebrand has received research support from National MS Society.
David E. Kvarnberg, MD Dr. Kvarnberg has nothing to disclose.
Andrew Ferree, MD, PhD Dr. Ferree has nothing to disclose.
D Kevin Horton No disclosure on file
Eduardo Arteaga Bracho Eduardo Arteaga Bracho has nothing to disclose.
Shruthishree Sukumar Shruthishree Sukumar has nothing to disclose.
Chafic Y. Karam, MD Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuroderm.
Mia T. Minen, MD, FAAN The institution of Dr. Minen has received research support from NIH. Dr. Minen has received intellectual property interests from a discovery or technology relating to health care. Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a First Contact-Primary Care Advisory Board Member with American Headache Society . Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PCORI grant on migraine evidence based map for stakeholders with ECRI .
Thomas E. Mullen, PhD Dr. Mullen has received personal compensation for serving as an employee of Quest Diagnostics. Dr. Mullen has received stock or an ownership interest from Quest Diagnostics.
Krishna Nalleballe, MD, FAAN Dr. Nalleballe has nothing to disclose.
Nakul Katyal, MD Dr. Katyal has nothing to disclose.
Rebecca K. Miller-Kuhlmann, MD Dr. Miller-Kuhlmann has nothing to disclose.
Matheus Alves A. Silva, MD Dr. Silva has nothing to disclose.
Ying Liu No disclosure on file
Isha Snehal, MBBS Dr. Snehal has nothing to disclose.
Liliana Montoya, MD Dr. Montoya has nothing to disclose.
Angelika Erwin Angelika Erwin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Angelika Erwin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Angelika Erwin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Angelika Erwin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Angelika Erwin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Angelika Erwin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Angelika Erwin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Angelika Erwin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme.
Eliza C. Miller, MD Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for medical malpractice cases. The institution of Dr. Miller has received research support from National Institutes of Health. Dr. Miller has a non-compensated relationship as a member of ASA Advisory Council with American Heart Association/American Stroke Association that is relevant to AAN interests or activities.
Negar Moheb, MD Dr. Moheb has nothing to disclose.
Han S. Lee Mr. Lee has nothing to disclose.
Neha Gandhi, MD Dr. Gandhi has nothing to disclose.
Temitope A. Lawal, MD Dr. Lawal has nothing to disclose.
Aimalohi Esechie, MD, PhD Dr. Esechie has nothing to disclose.
Michael L. Palm, MD, FAAN Dr. Palm has nothing to disclose.
Jacqueline Montes, PT, EdD, NCS Ms. Montes has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hoffman LaRoche. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. The institution of Ms. Montes has received research support from NIH/NICHD. The institution of Ms. Montes has received research support from Muscular Dystrophy Association. The institution of Ms. Montes has received research support from Cure SMA.
Zhenyuan Wang, PhD Dr. Wang has nothing to disclose.
Melissa Reider-Demer, DNP, MN, CNP Dr. Reider-Demer has nothing to disclose.
Shayan Torabi Moghaddam, DO Dr. Torabi Moghaddam has nothing to disclose.
Laurie Wagner Laurie Wagner has nothing to disclose.
Machteld E. Hillen, MD, FAAN The institution of Dr. Hillen has received research support from Genentech.
Lubna E. El Sheikh, Jr., MBBS Dr. El Sheikh has nothing to disclose.
Cedric Laloyaux, PhD Dr. Laloyaux has received personal compensation for serving as an employee of UCB.
Ryan Hays, MD, MBA, FAES, FAAN Dr. Hays has nothing to disclose.
David B. Burkholder, MD, FAAN The institution of Dr. Burkholder has received research support from Longboard pharmaceuticals.
Christopher Seet, MBBS Dr. Seet has nothing to disclose.
Nitin Butala, MD, FAAN Dr. Butala has nothing to disclose.
Sara B. Mitchell, MD Dr. Mitchell has nothing to disclose.
Rosario Maria S. Riel-Romero, MD, FAAN Dr. Riel-Romero has stock in Biointech. Dr. Riel-Romero has stock in Intuitive Surgical. Dr. Riel-Romero has stock in CRISPR. Dr. Riel-Romero has received personal compensation in the range of $100,000-$499,999 for serving as a Professor with LSU. An immediate family member of Dr. Riel-Romero has received personal compensation in the range of $100,000-$499,999 for serving as a Surgeon with VA.
Janardan S. Sivapalan Mr. Sivapalan has nothing to disclose.
William Souza Martins Ferreira Mr. Souza Martins Ferreira has nothing to disclose.
Junaid Ansari, MD Dr. Ansari has nothing to disclose.
Alejandro Gonzalez Aquines, Sr. Mr. Gonzalez Aquines has nothing to disclose.
Tina Duong Tina Duong has received personal compensation for serving as an employee of Roche. Tina Duong has received personal compensation for serving as an employee of Novartis. Tina Duong has received personal compensation for serving as an employee of Scholar Rock. Tina Duong has received personal compensation for serving as an employee of Genentech. Tina Duong has received personal compensation for serving as an employee of Novartis. Tina Duong has received personal compensation for serving as an employee of Sarepta. Tina Duong has received personal compensation for serving as an employee of Biogen. Tina Duong has received personal compensation for serving as an employee of Audentes. Tina Duong has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Tina Duong has received personal compensation in the range of $0-$499 for serving as a Consultant for Audentes. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sarepta. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. The institution of Tina Duong has received research support from biogen. The institution of Tina Duong has received research support from scholar rock.
Yi Dai No disclosure on file
Moon Han, PhD Dr. Han has nothing to disclose.
Ondrej Dostal The institution of Ondrej Dostal has received research support from Ministry of Education Youths and Sports.
Christopher J. Boes, MD, FAAN Dr. Boes has nothing to disclose.
Sam Payabvash No disclosure on file
Manuel Toledo No disclosure on file
Pavel Klein, MD, FAAN The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Sience. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alliance. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvelle Therapeutics. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Aquestive. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion. Dr. Klein has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for PrevEp. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Fenwick . Dr. Klein has received research support from DOD/CURE.
Carmen Serrano, MD, FAAN The institution of Dr. Serrano has received research support from Eli Lilly. The institution of Dr. Serrano has received research support from Abbvie.
Alexander G. Doyle, MD Dr. Doyle has nothing to disclose.
Tamara Strohm, MD Dr. Strohm has nothing to disclose.
Bhaskar Roy, MD, FAAN Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda Pharmaceuticals. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Roy has stock in Cabaletta bio. . The institution of Dr. Roy has received research support from Martin Shubik Fund for IBM at Yale University. The institution of Dr. Roy has received research support from Abcuro Pharmaceuticals.
Nizar Souayah, MD, FAAN Dr. Souayah has received publishing royalties from a publication relating to health care.
Morenikeji Komolafe, MD No disclosure on file
Daniel Zhou, MD Dr. Zhou has nothing to disclose.
Tania Reyna, MD, FAAN Dr. Reyna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Reyna has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Reyna has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Reyna has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics.
Maria Diaz Ordonez, MD Dr. Diaz Ordonez has nothing to disclose.
Jessica Falco-Walter, MD Dr. Falco-Walter has nothing to disclose.
Svetlana Blitshteyn, MD, FAAN Dr. Blitshteyn has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Law Office of Robert J. Krakow, P.C. Dr. Blitshteyn has received research support from Dysautonomia Information Network (DINET). Dr. Blitshteyn has received publishing royalties from a publication relating to health care. Dr. Blitshteyn has a non-compensated relationship as a Medical Advisor with Dysautonomia International non-profit that is relevant to AAN interests or activities. Dr. Blitshteyn has a non-compensated relationship as a Medical Advisor with Standing Up To POTS non-profit that is relevant to AAN interests or activities. Dr. Blitshteyn has a non-compensated relationship as a Medical Advisor with Dysautonomia Information Network non-profit that is relevant to AAN interests or activities. Dr. Blitshteyn has a non-compensated relationship as a Medical Adivsor with The Ehlers-Danlos Society non-profit that is relevant to AAN interests or activities.
Anna Zolyan, MD Dr. Zolyan has nothing to disclose.
Aaron Yarlas, PhD Dr. Yarlas has received personal compensation for serving as an employee of Ionis Pharmaceuticals. Dr. Yarlas has stock in Ionis Pharmaceuticals.
Musab Ali, MD Dr. Ali has nothing to disclose.
Maryum Shoukat, MD Dr. Shoukat has nothing to disclose.
Osama M. Abu-hadid, MD Dr. Abu-hadid has nothing to disclose.
Vasuki Dandu, MD Dr. Dandu has nothing to disclose.
Hina N. Dave, MD Dr. Dave has nothing to disclose.
Brandon M. Ghislain Mr. Ghislain has nothing to disclose.
Satoru Morimoto Satoru Morimoto has nothing to disclose.
Guido D. Vazquez II, PhD Dr. Vazquez has nothing to disclose.
Pradeep Kumar Gunasekaran No disclosure on file
Lindsay Rechtman The institution of Lindsay Rechtman has received research support from ATSDR.
Basil T. Darras, MD The institution of Dr. Darras has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Darras has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. The institution of Dr. Darras has received research support from National Institutes of Health/National Institute of Neurological Disorders and Stroke,. The institution of Dr. Darras has received research support from Slaney Family Fund for SMA. The institution of Dr. Darras has received research support from Spinal Muscular Atrophy Foundation. The institution of Dr. Darras has received research support from CureSMA. The institution of Dr. Darras has received research support from Working on Walking Fund . The institution of Dr. Darras has received research support from CHERISH, CS2/CS12 . The institution of Dr. Darras has received research support from Biogen for CS11. The institution of Dr. Darras has received research support from AveXis. The institution of Dr. Darras has received research support from Sarepta Pharmaceuticals. The institution of Dr. Darras has received research support from PTC Therapeutics. The institution of Dr. Darras has received research support from Roche. The institution of Dr. Darras has received research support from Santhera. The institution of Dr. Darras has received research support from Scholar Rock. The institution of Dr. Darras has received research support from Fibrogen. The institution of Dr. Darras has received research support from Summit. Dr. Darras has received publishing royalties from a publication relating to health care. Dr. Darras has received publishing royalties from a publication relating to health care.
Paul Mehta No disclosure on file
Junaid H. Siddiqui, MD Dr. Siddiqui has nothing to disclose.
Alejandra Garland Becerra, MD Dr. Garland Becerra has nothing to disclose.
Emmanuel Jesus Escobar Valdivia, MD Dr. Escobar Valdivia has nothing to disclose.
Vivekananda Datta Vivekananda Datta has received personal compensation for serving as an employee of Quest Diagnostics.
Inna Keselman, MD, PhD Dr. Keselman has nothing to disclose.
Eugenie Girouard, MD Eugénie Girouard has nothing to disclose.
Sukanthi Kovvuru, MD Dr. Kovvuru has nothing to disclose.
Frank Salamone Mr. Salamone has nothing to disclose.
Nuran Dilek No disclosure on file
Daniel Torres, MD Dr. Torres has received publishing royalties from a publication relating to health care.
Aaisha Mozumder, MD Dr. Mozumder has nothing to disclose.
Patrice LaLive, MD Dr. LaLive has nothing to disclose.
Sinead Murphy Sinead Murphy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Sinead Murphy has received research support from Novartis.
Franca Cambi, MD The institution of Dr. Cambi has received research support from NIH.
Samantha K. Holden, MD, MS, FAAN Dr. Holden has nothing to disclose.
Mayowa Owolabi, MD, FAAN Dr. Owolabi has nothing to disclose.
Jessica Abreu Garcia, MD Dr. Abreu Garcia has nothing to disclose.
Jennifer Jain, MD, BSc Dr. Jain has nothing to disclose.
Deanna Saylor, MD, MHS The institution of Dr. Saylor has received research support from National Institutes of Health. The institution of Dr. Saylor has received research support from National Multiple Sclerosis Society. The institution of Dr. Saylor has received research support from American Academy of Neurology. The institution of Dr. Saylor has received research support from United States Department of State. Dr. Saylor has a non-compensated relationship as a Member of multiple committees and task forces focused on improving access to MS medications to people across the world with Multiple Sclerosis International Federation that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the Neurology and COVID19 committee with World Health Organization that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the International Outreach Committee, Junior and Early Career Membership Committee, and Educational Innovation Commitees with American Neurological Association that is relevant to AAN interests or activities.
Valeriya Levitan, MD Dr. Levitan has nothing to disclose.
J. H. Harvey, DO Dr. Harvey has received personal compensation for serving as an employee of RSC Diagnostics. The institution of Dr. Harvey has received research support from GW Pharmaceuticals. The institution of Dr. Harvey has received research support from Cerevel Pharmaceuticals. The institution of Dr. Harvey has received research support from UCB Pharmaceuticals.
Johnny A. Sanabria Lopez, MD Dr. Sanabria Lopez has nothing to disclose.
Kavita M. Grover, MD, FAAN Dr. Grover has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst.
Vincent H. Bargnes III Mr. Bargnes has received research support from Harry Dent Family Foundation.
Mashina Chomba, MBChB Dr. Chomba has nothing to disclose.
Sean O'Riordan, MD Dr. O'Riordan has nothing to disclose.
Harold J. Weinberg, MD Dr. Weinberg has nothing to disclose.
Abolfazl Avan, MD, PhD Dr. Avan has nothing to disclose.
Benedict R. Pereira, MD Dr. Pereira has nothing to disclose.
Laurice T. Yang, MD, MHA The institution of Dr. Yang has received research support from Alzheimer's Disease Research Center (ADRC). The institution of Dr. Yang has received research support from Pacific Northwest Udall Center . The institution of Dr. Yang has received research support from Biogen/Parkinson's Study Group . The institution of Dr. Yang has received research support from Eli Lily . The institution of Dr. Yang has received research support from Michael J. Fox Foundation For Parkinson's Research . The institution of Dr. Yang has received research support from Sanofi . Dr. Yang has received personal compensation in the range of $500-$4,999 for serving as a Chair, Workgroup with American Academy of Neurology .
Marta Valente No disclosure on file
Ali M. Al-Salahat, MBBS Dr. Al-Salahat has nothing to disclose.
Carlos Santiago Claverie, MD No disclosure on file
Casey J. Judge, DO Dr. Judge has nothing to disclose.
Melody T. Asukile, MBBS Dr. Asukile has received research support from Royal Society for Tropical Medicine and Hygiene. Dr. Asukile has received personal compensation in the range of $0-$499 for serving as a meeting speaker with American Neurological Association.
Kateryna Kurako, MD Dr. Kurako has nothing to disclose.
Lorne H. Zinman, MD Dr. Zinman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, MTP, AB Science, Cytokinetics, Amylyx. Dr. Zinman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx.
Noelia C. Morales, MD Dr. Morales has nothing to disclose.
Kelsey M. Smith, MD The institution of Dr. Smith has received research support from CURE Epilepsy. The institution of Dr. Smith has received research support from UCB Pharmaceuticals.
Alison Herman Ms. Herman has nothing to disclose.
Suman Siddamreddy Suman Siddamreddy has nothing to disclose.
Sujata P. Thawani, MD Dr. Thawani has nothing to disclose.
Srinivasa Rao Kundeti Srinivasa Rao Kundeti has nothing to disclose.
Katherine A. Zarroli, MD Dr. Zarroli has nothing to disclose.
Claire Ruane Ms. Ruane has nothing to disclose.
Catherine Marti No disclosure on file
Pojen Deng, MD Dr. Deng has nothing to disclose.
Shibeshih Belachew, MD Dr. Belachew has received personal compensation for serving as an employee of Biogen Inc. Dr. Belachew has received stock or an ownership interest from Biogen Inc.
Jonathan Donnelly, MB BCh BaO Dr. Donnelly has nothing to disclose.
John K. Lee, MD, PhD Dr. Lee has nothing to disclose.
Franco E. Appiani, MD Dr. Appiani has nothing to disclose.
Michael Isfort, MD Dr. Isfort has nothing to disclose.
Alejandro A. Rabinstein, MD, FAAN Dr. Rabinstein has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shionogi . Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainomix. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical care/NCS-Springer. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters/UptoDate. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO/DynaMed. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. The institution of Dr. Rabinstein has received research support from Chiesi. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care.
Ihedinachi Ndukwe, MD Dr. Ndukwe has nothing to disclose.
Parisorn Thepmankorn Ms. Thepmankorn has received personal compensation for serving as an employee of Johnson and Johnson.
Muhammad F. Bilal, MD, FAAN Dr. Bilal has nothing to disclose.
Kolawole W. Wahab, MD, FAAN Dr. Wahab has nothing to disclose.
Sherri A. Braksick, MD, FAAN Dr. Braksick has nothing to disclose.
Akanksha Sharma, MD Dr. Sharma has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. The institution of Dr. Sharma has received research support from Chimerix. The institution of Dr. Sharma has received research support from Incyte. The institution of Dr. Sharma has received research support from Novocure. The institution of Dr. Sharma has received research support from Apollomix. Dr. Sharma has received personal compensation in the range of $0-$499 for serving as a Speaker with Project Ronin. Dr. Sharma has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with National Brain Tumor Society. Dr. Sharma has a non-compensated relationship as a Advisory Board with Elevate Med that is relevant to AAN interests or activities.
Ming Hui Yong, MD Dr. Yong has nothing to disclose.
Megan G. Pino Ms. Pino has nothing to disclose.
Adam B. Edwards, MD Dr. Edwards has nothing to disclose.
Laura Mullen, MD Ms. Mullen has nothing to disclose.
Miriam L. Freimer, MD, FAAN Dr. Freimer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alexion. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for J and J. The institution of Dr. Freimer has received research support from Alnylum. The institution of Dr. Freimer has received research support from UCB. The institution of Dr. Freimer has received research support from NIH. The institution of Dr. Freimer has received research support from Janssen. Dr. Freimer has received research support from Avidity. Dr. Freimer has received research support from Fulcrum. Dr. Freimer has received personal compensation in the range of $10,000-$49,999 for serving as a presenations/teaching with UCB.
Matthew Purbaugh, MD Dr. Purbaugh has nothing to disclose.
Nicholas L. Zalewski, MD Dr. Zalewski has nothing to disclose.
Jeffrey Zhang No disclosure on file
Duncan Brown Duncan Brown has received personal compensation for serving as an employee of Akcea Therapeutics, Inc. Duncan Brown has received stock or an ownership interest from Akcea Therapeutics, Inc.
Stephen Apple Stephen Apple has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma America, Inc.
Narges Moghimi, MD Dr. Moghimi has nothing to disclose.
Christianne Mojica Christianne Mojica has nothing to disclose.
Kevin N. Sheth, MD, FAAN Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
Catherine Boldig, DO Dr. Boldig has nothing to disclose.
Ghazala Perven, MD Dr. Perven has nothing to disclose.
Michael B. Beeler, DO Dr. Beeler has received personal compensation for serving as an employee of United States Navy.
Jason Massa, DO Dr. Massa has nothing to disclose.
David K. Chan, MD Dr. Chan has nothing to disclose.
Habib Georges Moutran Barroso, MD Dr. Moutran Barroso has nothing to disclose.
Mirela Cerghet, MD, PhD, FAAN Dr. Cerghet has nothing to disclose.
Gary W. Clauser, MD Dr. Clauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bigoen . The institution of Dr. Clauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme. Dr. Clauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech . Dr. Clauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Genzyme. Dr. Clauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Clauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Novartid.
Erafat Rehim, MD Dr. Rehim has nothing to disclose.
Yugaku Date, MD, PhD Dr. Daté has nothing to disclose.
Anthony A. Hanna Mr. Hanna has nothing to disclose.
Mataa Mataa No disclosure on file
Valeria A. Sansone, MD Dr. Sansone has nothing to disclose.
Kalea L. Colletta, DO Dr. Colletta has nothing to disclose.
Rufus O. Akinyemi, MD Dr. Akinyemi has nothing to disclose.
Lonni Schultz, PhD Dr. Schultz has nothing to disclose.
Christopher McGuigan, MD Dr. McGuigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. McGuigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. McGuigan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. McGuigan has received research support from Biogen. The institution of Dr. McGuigan has received research support from Novartis. The institution of Dr. McGuigan has received research support from Roche.
Ghazala Hayat, MBBS, FAAN Dr. Hayat has received personal compensation in the range of $500-$4,999 for serving as a Consultant for kabafusion. Dr. Hayat has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for csl. Dr. Hayat has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alexion. Dr. Hayat has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for MTPA. Dr. Hayat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for alexion. Dr. Hayat has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for kabafusion.
Sanjeeva R. Onteddu, MD, FAAN Dr. Onteddu has nothing to disclose.
Benjamin Yong Qiang Tan Benjamin Yong Qiang Tan, 8130 has nothing to disclose.
Aaron E. Izenberg, MD Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexxion. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alnylam.
Chadi Darwich, MD Dr. Darwich has nothing to disclose.
Robin L. Brey, MD The institution of Dr. Brey has received research support from State of Texas. Dr. Brey has a non-compensated relationship as a Task Force Member with AAN that is relevant to AAN interests or activities.
Saad Karim, MD Dr. Karim has nothing to disclose.
Christine C. Guo, PhD No disclosure on file
Melissa Hagan Melissa Hagan has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma America, Inc..
Montserrat Vera Llonch Montserrat Vera Llonch has received personal compensation for serving as an employee of Akcea. Montserrat Vera Llonch has received stock or an ownership interest from Akcea.
Andrew R. Snavely Mr. Snavely has nothing to disclose.
Faizan Aslam, MBBS Dr. Aslam has nothing to disclose.
Sydney V. Palka, MD Dr. Palka has nothing to disclose.
Ladislav Pazdera, MD, FAAN Dr. Pazdera has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Pazdera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva.
Marisara Dieppa, MD Dr. Dieppa has nothing to disclose.
Arielle M. Kurzweil, MD, FAAN Dr. Kurzweil has nothing to disclose.
Justin Kinsella, MD Dr. Kinsella has nothing to disclose.
Xiaowei W. Su, MD, PhD The institution of Dr. Su has received research support from H. G. Barsumian, M.D. Memorial Fund.
Maxime Berube-Desrosiers, MD Dr. Berube-Desrosiers has nothing to disclose.
David D. Adams David D. Adams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ALNYLAM. David D. Adams has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer.
Leonard L. Yeo, MBBS The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca. The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for stryker. Dr. Yeo has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for NUHS. Dr. Yeo has received stock or an ownership interest from cereflo. The institution of Dr. Yeo has received research support from NMRC.
Emma Bowden No disclosure on file
Anika Morgado Ms. Morgado has nothing to disclose.
Niall Tubridy, MD Dr. Tubridy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis .
Deborah Rose, MD Dr. Rose has nothing to disclose.
Brian D. Moseley, MD Dr. Moseley has received personal compensation for serving as an employee of UCB. Dr. Moseley has received personal compensation for serving as an employee of Neurocrine Biosciences Inc. Dr. Moseley has stock in UCB. Dr. Moseley has stock in Neurocrine Biosciences.
Hui Jin Chiew, MBBS Dr. Chiew has nothing to disclose.
Angela L. Genge, MD Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AL-S Pharma. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Genge has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Genge has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Quralis. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Genge has received personal compensation in the range of $0-$499 for serving as a Consultant for WAVE.
Stephen J. Kolb, MD, PhD Dr. Kolb has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AveXis. Dr. Kolb has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CureSMA. The institution of Dr. Kolb has received research support from NIH. The institution of Dr. Kolb has received research support from AveXis. The institution of Dr. Kolb has received research support from NIH.
Carlos F. Martinez, MD Dr. Martinez has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Janssen Cilag.
Aakashi Shah, MD Dr. Shah has nothing to disclose.
Mariana Nelson, PhD Dr. Nelson has received personal compensation for serving as an employee of Allergan, an AbbVie company. Dr. Nelson has received stock or an ownership interest from Allergan, an AbbVie company.
Batool A. Hussain, MD, MBBS Dr. Hussain has nothing to disclose.
Paul Wilkerson, DO No disclosure on file